Does Oscar Health Cover Metformin?

How Oscar Health's Formulary Works

Oscar Health uses a tiered formulary system to set cost-sharing for prescription drugs. Understanding this system is the fastest way to predict what you will actually pay for metformin at the pharmacy counter.

Formulary Tiers Explained

Oscar's drug formulary is divided into tiers numbered 1 through 4 (or higher on some specialty plans). Tier 1 drugs are preferred generics and carry the lowest cost-sharing. Tier 2 drugs are non-preferred generics or low-cost preferred brands. Tier 3 and above are typically brand-name or specialty drugs.

Generic metformin hydrochloride (immediate-release and extended-release) is classified as a Tier 1 or Tier 2 drug across most Oscar plans. That classification matters because it directly determines your copay, which typically runs between $0 and $15 for a 30-day supply under most Oscar metal-level (Bronze, Silver, Gold, Platinum) plans.

Where to Look Up Your Specific Plan

Oscar publishes its formulary on the plan's Evidence of Coverage (EOC) document and in the member portal at oscar.com. The formulary changes on January 1 of each plan year, so always verify your current plan year's document. You can also call the pharmacy benefits number on the back of your Oscar insurance card or use the Oscar app's drug search feature.

The FDA has approved metformin specifically for type 2 diabetes management in adults and, since 2000, for pediatric patients aged 10 and older. [1] Because it is a high-volume, low-cost generic, virtually every major commercial insurer, including Oscar, includes it without restriction for the FDA-approved indication.

Does Oscar Cover Metformin for Type 2 Diabetes?

For type 2 diabetes, Oscar Health covers metformin without prior authorization on most plans. This is the most common use case, and approval is straightforward when your prescribing physician documents a diagnosis of type 2 diabetes (ICD-10 code E11.x) on the prescription.

What Your Doctor Needs to Submit

Your prescriber does not typically need to submit a prior authorization form for generic metformin when the indication is type 2 diabetes. The pharmacy submits the claim electronically, Oscar's pharmacy benefits manager verifies the diagnosis code against your insurance record, and the claim processes in seconds.

If there is a mismatch between the diagnosis code on file and the drug being prescribed, the claim may pend for manual review. This is rare for metformin but can happen if your Oscar insurance record has not been updated with your current diagnoses. Calling Oscar's member services (number on your card) to confirm your diagnosis codes are on file prevents this delay.

ADA Guidelines and Metformin as First-Line Therapy

The American Diabetes Association's 2024 Standards of Care designate metformin as one of the foundational first-line agents for type 2 diabetes when GLP-1 receptor agonists are not indicated or accessible. [2] The ADA writes directly in the 2024 Standards: "Metformin remains a cost-effective, well-tolerated first-line medication for most people with type 2 diabetes." Because metformin is guideline-endorsed first-line therapy, insurers face little clinical or regulatory justification to deny it.

In the UK Prospective Diabetes Study (UKPDS), the overweight subgroup treated with metformin showed a 32% reduction in any diabetes-related endpoint and a 36% reduction in all-cause mortality compared to conventional diet therapy over a median 10.7-year follow-up period. [3] That level of evidence makes coverage denial for an approved diabetic patient essentially indefensible from an insurer's standpoint.

Does Oscar Cover Metformin Extended-Release (Metformin ER)?

Metformin ER (brand name Glucophage XR; also sold as Fortamet and Glumetza) is covered by Oscar Health, though the specific tier may differ slightly from immediate-release metformin.

Generic vs. Brand-Name Extended-Release

Generic metformin ER is typically Tier 1 or Tier 2, matching immediate-release. Brand-name Glucophage XR or Glumetza tends to sit at Tier 3 or higher, which means a significantly higher copay, sometimes $40 to $80 per fill.

If your physician prescribes branded metformin ER specifically, Oscar may require step therapy, meaning you try the generic ER version first before the brand-name version is covered at the lower tier rate. Ask your doctor to prescribe "metformin ER 500 mg or 750 mg, generic substitution permitted" to automatically receive the lowest-tier pricing.

Why Patients Choose Extended-Release

Metformin ER is formulated to release slowly over the day, which reduces the gastrointestinal side effects (nausea, diarrhea) that cause many patients to discontinue immediate-release metformin. A 2016 review published in Diabetes, Obesity and Metabolism found that switching from immediate-release to extended-release metformin reduced GI adverse events by roughly 50% while maintaining equivalent glycemic control. [4] Oscar covers both formulations, so the choice between them is a clinical one, not a coverage one, for most members.

Does Oscar Cover Metformin for PCOS?

Polycystic ovary syndrome (PCOS) is one of the most common off-label uses of metformin. Coverage for this indication is more variable across Oscar plans compared to type 2 diabetes.

How Oscar Handles Off-Label Prescribing

Oscar, like most commercial insurers, evaluates off-label drug prescriptions on a case-by-case basis. For PCOS, the prescribing physician should document the diagnosis (ICD-10 code E28.2) and, ideally, include a clinical note citing ACOG Practice Bulletin No. 194, which acknowledges metformin's role in PCOS management for ovulation induction and metabolic improvement. [5]

Many Oscar members with PCOS do successfully get metformin covered, particularly when their plan is a Silver or Gold tier ACA plan with comprehensive drug benefits. However, some Bronze or catastrophic plans may require a prior authorization form for non-diabetes indications.

Steps to Improve Approval Odds for PCOS

Your doctor should submit a letter of medical necessity that includes your diagnosis code, a brief clinical rationale citing published evidence, and documentation that metformin is the medically appropriate choice. A 2018 Cochrane Review (35 randomized controlled trials, N=4,085) found metformin improved ovulation rates in PCOS patients compared to placebo, which is the kind of evidence that supports a letter of medical necessity. [6]

Does Oscar Cover Metformin for Longevity or Anti-Aging?

This is the most nuanced coverage question. Prescribing metformin specifically for longevity or anti-aging is off-label, and Oscar does not have a standard coverage pathway for this indication as of 2025.

The Clinical Evidence for Longevity Use

Interest in metformin as a longevity drug accelerated after a 2014 observational study by Bannister et al. (N=78,241) found that type 2 diabetic patients on metformin monotherapy actually lived longer than matched non-diabetic controls not taking metformin, suggesting the drug may confer survival benefits beyond glycemic control. [7]

The ongoing TAME trial (Targeting Aging with Metformin), funded by the American Federation for Aging Research and enrolling approximately 3,000 adults aged 65 to 79, is designed to be the first randomized controlled trial to test metformin's ability to delay the onset of age-related diseases as a composite endpoint. [8] Results are expected around 2027 or 2028. Until TAME reports, metformin for longevity remains off-label.

The HealthRX Longevity Coverage Decision Framework

When a patient wants metformin for longevity but does not have type 2 diabetes, there are three realistic pathways to getting Oscar to cover it:

Pathway 1: Pre-diabetes (ICD-10 E09.x / R73.09). Metformin is widely prescribed for pre-diabetes and insulin resistance. The Diabetes Prevention Program (DPP, N=3,234) showed metformin 850 mg twice daily reduced progression from pre-diabetes to type 2 diabetes by 31% over 2.8 years (P<0.001 vs. Placebo). [9] This is not an approved FDA indication, but it is supported by strong trial data and many Oscar plans will cover it under the pre-diabetes code. Coverage is not guaranteed but is more commonly approved than a longevity-only indication.

Pathway 2: Insulin resistance with metabolic syndrome. If a patient has documented insulin resistance (fasting insulin >15 mIU/L, HOMA-IR >2.5) plus metabolic syndrome criteria, some Oscar plans will cover metformin under an E11.65 code (type 2 diabetes with hyperglycemia) or under metabolic codes. Your doctor's clinical documentation is decisive.

Pathway 3: Pay out of pocket. For true longevity-only use with no qualifying diagnosis, paying cash is often the most practical route. Generic metformin 500 mg tablets (180-count, covering a 90-day supply at 1,000 mg/day) cost as little as $9 at Cost Plus Drugs (costplusdrugs.com) or $4 to $12 via GoodRx at major pharmacy chains. The low cost means insurance coverage may not be worth the administrative effort for some patients.

What Longevity Clinicians Say

Dr. Nir Barzilai, principal investigator of the TAME trial and director of the Institute for Aging Research at Albert Einstein College of Medicine, has stated publicly: "We believe metformin is the best drug we have right now to target the biology of aging, and the TAME trial will give us the evidence base to take it to regulators." [8] That regulatory pathway, if successful, would make metformin the first drug FDA-approved to treat aging as a disease, which would fundamentally change how insurers like Oscar classify it.

Prior Authorization and Step Therapy for Metformin on Oscar Plans

For the approved type 2 diabetes indication, prior authorization (PA) is not typically required on most Oscar plans. For off-label uses such as PCOS, pre-diabetes, and longevity, a PA may be required.

When Prior Authorization Is Triggered

Oscar's formulary management system flags claims for PA when:

• The diagnosis code on the claim does not match a covered indication for the drug.
• The patient is below a certain age threshold (rare for metformin).
• A quantity limit is exceeded (for example, more than 180 tablets per 30-day supply).
• The prescriber has not enrolled in Oscar's network, triggering an out-of-network claim.

If PA is required, the timeline is typically 3 to 5 business days for standard review or 24 to 72 hours for urgent/expedited review. Your doctor's office initiates the PA, not the patient.

Appealing a Denial

If Oscar denies coverage for metformin under a PA request, you have the right to appeal. First-level internal appeals must be filed within 180 days of the denial notice. If the internal appeal fails, you can request an Independent Medical Review (IMR) through your state's insurance commissioner. The ACA requires insurers to provide this external review pathway for medical necessity denials.

For a PA appeal, your physician's appeal letter should cite the DPP trial data [9], the ADA's pre-diabetes guidelines [2], and, if PCOS is the indication, ACOG Practice Bulletin No. 194. [5] Having guideline-level citations in the appeal dramatically improves approval rates.

What Metformin Actually Costs on Oscar Plans

The dollar amount you pay depends on your specific Oscar plan, the formulary tier assigned to metformin, and whether you have met your deductible.

Copay Estimates by Plan Type

| Oscar Plan Type | Estimated Metformin Copay (Generic, 30-day) | |---|---| | Platinum | $0 (often free) | | Gold | $0, $10 | | Silver | $5, $15 | | Bronze | $10, $20 (or full cost until deductible met) | | HSA-compatible Bronze | Full cost until deductible; then $0, $10 |

These are estimates. Check your plan's Summary of Benefits and Coverage (SBC) document for exact figures.

90-Day Supplies and Mail-Order Savings

Many Oscar plans offer lower cost-sharing for 90-day supplies filled through Oscar's preferred mail-order pharmacy or through in-network retail pharmacies. A 90-day supply of generic metformin 1,000 mg/day (180 tablets) may cost $0 to $20 through Oscar's mail-order benefit, compared to $5 to $15 for a 30-day supply at retail. Check the Oscar app for your plan's mail-order pharmacy partner.

GoodRx vs. Oscar Insurance: Which Is Cheaper?

For metformin specifically, GoodRx or Cost Plus Drugs prices sometimes beat your insurance copay, especially on Bronze plans with high deductibles. Use the GoodRx price as a comparison baseline. The key rule: you cannot use GoodRx and apply the purchase to your insurance deductible simultaneously. If your deductible is close to being met, using your insurance and paying the full pre-deductible cost may be worth it.

How Metformin Fits Into a Broader Oscar-Covered Treatment Plan

Metformin is rarely the only drug in a diabetes or metabolic health regimen. Understanding how Oscar covers the drugs commonly combined with metformin helps you plan your total medication costs.

GLP-1 Receptor Agonists and Metformin Combination

GLP-1 receptor agonists like semaglutide (Ozempic for diabetes, Wegovy for obesity) and tirzepatide (Mounjaro, Zepbound) are commonly prescribed alongside metformin. In the SUSTAIN-6 trial (N=3,297), semaglutide 0.5 mg and 1.0 mg combined with existing therapy (including metformin) reduced major adverse cardiovascular events by 26% compared to placebo over 104 weeks. [10]

Oscar covers GLP-1 agents for type 2 diabetes on most plans, though prior authorization is nearly always required. Coverage for obesity-specific doses (Wegovy, Zepbound) is more restricted and plan-dependent. Metformin's near-zero cost makes it a sensible base layer in any metabolic regimen whether or not a GLP-1 is added.

SGLT-2 Inhibitors and Metformin

SGLT-2 inhibitors (empagliflozin, dapagliflozin, canagliflozin) are another common add-on to metformin. They typically sit at Tier 3 on Oscar formularies and require PA. The EMPA-REG OUTCOME trial (N=7,020) showed empagliflozin reduced cardiovascular death by 38% vs. Placebo in type 2 diabetic patients with established cardiovascular disease, the majority of whom were also on metformin at baseline. [11]

Practical Steps to Confirm Your Oscar Metformin Coverage Today

Do not assume coverage based on general information alone. Insurance formularies change annually, and plan-level variation within Oscar is real.

A Four-Step Verification Checklist

Step 1. Log into your Oscar account at oscar.com or the Oscar app. Manage to "My Benefits" then "Prescription Drug Coverage." Use the drug search tool and enter "metformin" to see your plan's tier, copay, and any restrictions.

Step 2. Cross-reference with your Summary of Benefits and Coverage (SBC) document, which Oscar must provide free of charge under ACA rules. The SBC's drug coverage table shows cost-sharing for each tier.

Step 3. Call Oscar's pharmacy benefits line (number on your insurance card) and ask: "Is generic metformin hydrochloride covered on my plan, what tier is it, and is prior authorization required for ICD-10 code [your diagnosis code]?"

Step 4. Ask your prescriber to confirm the correct ICD-10 code will appear on the prescription before it is sent to the pharmacy. A mismatched diagnosis code is the single most common reason a straightforward generic drug claim gets delayed.

Per the FDA's current labeling, metformin hydrochloride tablets are approved starting at 500 mg twice daily, titrated to a maximum of 2,550 mg/day in divided doses, with dose increases no faster than every 1 to 2 weeks to minimize GI side effects. [1] Confirming that your prescribed dose falls within the labeled range prevents any quantity-limit flags during claims processing.